February 10, 2020
Continued Usage of Dupilumab Shows Atopic Dermatitis Treatment Results
Severe atopic dermatitis (AD) produces painful, itchy and unsightly patches that disrupt sleep and have been linked to increased risk of depression. Now researchers have analyzed findings from a randomized follow-up trial in adults from two previous studies (SOLO 1 and SOLO 2) and found that maintenance monotherapy with dupilumab (Dupixent, Regeneron) at 300 mg...
Mothers with Depression May Cause Atopic Dermatitis in Their Children
Atopic dermatitis (AD), a chronic, inflammatory skin disease that causes itchy, painful patches on patients has been linked to many mental health disorders, such as depression, anxiety, and suicidal tendencies. A study conducted by Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology at the George Washington University School of Medicine and Health Sciences, took...
Studies Show that Atopic Dermatitis is Harder to Treat in Black Patients
Eczema sufferers, also known as atopic dermatitis, can attest to how difficult is to identify a suitable treatment plan. This is especially troubling because symptoms include severe itching, scaly rashes, extremely dry skin and inflammation. This battle can be even more trying for Black people with the condition. A recent study published in Annals of...